Lactose Intolerance Clinical Trial
Official title:
A Proof-of-concept Study to Evaluate the Effect and the Tolerability of a Novel Combination of Lactase Enzyme and Ligilactobacillus Salivarius DSM 34078 in Individuals With Lactose Intolerance
The goal of this clinical trial is to test whether a new combination of lactase and bacterial strain (L. Salivarius DSM 34078) can provide longer lasting beneficial effects on lactose digestion and gastrointestinal symptoms compared to lactase alone in people with lactose intolerance.
Participants will attend 3 visits (V0, V1, V2). Visit 0 is a screening/baseline visit (5 to 10 days before Visit 1), where participants will be checked for inclusion and exclusion criteria, and undergo a lactose challenge (drink a cup of lactose containing water) followed by a hydrogen breath test (HBT) and Carbohydrate Perception Questionnaire (CPQ) measured at intervals over 3 hours. At Visit 1, eligible participants are randomized into one of the four study arms: Lactase and bacterial strain combination in a capsule; lactase and bacterial strain combination in separate capsules, lactase only, or placebo. Each Visit 1 and Visit 2 takes about 8 hours, where participants take the investigational product (IP) before the first lactose challenge (with first HBT and first CPQ for 3 hours), followed by a 2-hour break with standardized meal provided, and undergo a second lactose challenge (with second HBT and second CPQ for another 3 hours). Visit 2 is scheduled one week after Visit 1, where participants take the IP once daily at home for a week and fill in a diary between Visit 1 and 2. Stool samples are collected at Visit 1 and 2. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
| Completed |
NCT02518295 -
β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion
|
N/A | |
| Completed |
NCT00599859 -
Effects of Lactose on Fecal Microflora
|
N/A | |
| Completed |
NCT02636413 -
Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance
|
Phase 4 | |
| Completed |
NCT02406469 -
Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior
|
Phase 4 | |
| Terminated |
NCT00247806 -
Prevalence of Lactose Intolerance Following Stem Cell Transplantation
|
Phase 1 | |
| Completed |
NCT03814668 -
Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution
|
N/A | |
| Completed |
NCT03860051 -
Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.
|
||
| Completed |
NCT02703987 -
HYBRID: Hydrogen Breath Test in Lactose Digestion
|
N/A | |
| Completed |
NCT00395954 -
Amount of Lactose Causing Symptoms in Lactose Intolerant People
|
Phase 0 | |
| Completed |
NCT01593800 -
The Effect of Probiotics on Lactose Intolerance
|
N/A | |
| Completed |
NCT04164394 -
Effect of I31 Probiotic on Lactose Intolerance
|
N/A | |
| Recruiting |
NCT05668468 -
A Bifido Bacteria to Improve Lactose Digestion and Tolerance
|
N/A | |
| Completed |
NCT03563846 -
Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
|
Phase 1 | |
| Recruiting |
NCT02085889 -
Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders
|
||
| Completed |
NCT03597516 -
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
|
Phase 3 | |
| Not yet recruiting |
NCT03563859 -
Evaluation of Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
|
Phase 3 | |
| Completed |
NCT02171403 -
Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls
|
N/A | |
| Completed |
NCT01145586 -
A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia
|
Phase 3 | |
| Completed |
NCT02902016 -
Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies
|
N/A |